-+ 0.00%
-+ 0.00%
-+ 0.00%

StoneX Maintains Buy on NeoGenomics, Raises Price Target to $20

Benzinga·10/06/2026 12:40:34
语音播报
StoneX analyst Bruce D. Jackson maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $16 to $20.